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Summary
Background:	 Real-	world	 data	 from	 different	 levels	 of	 hospital	 specialisation	would	
help	to	understand	if	differences	in	management	between	women	and	men	with	acute	
coronary	syndrome	(ACS)	are	still	a	priority	target.	We	aimed	to	identify	sex	inequali-
ties	in	management	of	patients	with	different	types	of	ACS.
Methods:	We	analysed	1757	patients	with	a	non-	ST-	elevation	ACS	(NSTEACS)	and	
1184	with	 ST	 elevation	myocardial	 infarction	 (STEMI)	 or	 left	 bundle	 branch	 block	
(non-	classifiable	(NC)	ACS	(STEMI/NC	ACS	group),	consecutively	discharged	from	ten	
Portuguese	hospitals	with	different	specialisation	levels,	between	2008	and	2010.	We	
estimated	odds	ratios	(OR)	and	95%	confidence	intervals	(95%	CI)	for	the	association	
between	 sex	 and	 the	 performance	 of	 coronary	 angiography,	 reperfusion	 and	
revascularisation.
Results:	Among	STEMI/NC	ACS,	men	had	higher	probability	of	performing	coronary	
angiography	 than	 women	 (adjusted	 OR	=	1.64,	 95%	 CI:	 1.11-	2.44),	 while	 among	
NSTEACS	 patients	 there	was	 no	 significant	 difference	 by	 sex	 (adjusted	OR	=	1.26,	
95%	CI:	0.99-	1.62).	In	patients	who	underwent	coronary	angiography,	there	was	no	
difference	in	proportion	of	women	and	men	submitted	to	revascularisation,	regardless	
of	 the	ACS	 type.	Although	men	with	STEMI/NC	ACS	were	more	 likely	 to	undergo	
reperfusion	(crude	OR	=	2.17,	95%	CI:	1.68-	2.81),	the	effect	became	not	significant	
after	multivariable	adjustment	(adjusted	OR	=	1.33,	95%	CI:	0.96-	1.84).
Conclusion:	Women	diagnosed	with	STEMI/NC,	but	not	NSTEACS,	had	lower	proba-
bility when compared with men to be submitted to coronary angiography. There was 
no	difference	in	performance	of	reperfusion	and	revascularisation	by	sex.
1  | INTRODUCTION
In	 the	 last	decades,	one	of	 the	major	determinants	of	 the	decrease	
in coronary heart disease (CHD) mortality in Europe, in women and 
men,	was	a	more	effective	access	to	coronary	angiography.1 However, 
recent	data	show	that	men	with	an	acute	coronary	syndrome	(ACS)	
are	still	more	likely	to	undergo	an	invasive	approach.2 In Portugal, be-
tween	2010	and	2013,	16.5%	of	patients	with	non-	ST-	elevation	myo-
cardial	 infarction,	mostly	women,	were	 treated	with	 a	 conservative	
strategy.3	Although	from	2002	to	2013	a	three-	fold	 increase	 in	pri-
mary	angioplasty	was	observed,	the	proportion	of	women	remained	
approximately	the	same	(24.5%	and	26.2%,	respectively).4 These data 
were	obtained	from	registries	that	included	patients	admitted	to	car-
diology departments, but not to other departments, and to hospitals 
offering	 differentiated	 care,	 and	 therefore	might	 not	 represent	 the	
national	 trends	 in	 the	 invasive	 diagnostic-	therapeutic	 approach	 of	
women	and	men	with	ACS.
The	decrease	in	CHD	mortality	in	Portugal	was	found	to	be	greater	
among women compared to men,5	the	result	of	effective	primary	and/
or secondary prevention measures implemented in this group. Changes 
in	the	major	cardiovascular	risk	factors	in	Portugal	contributed	signifi-
cantly more to the CHD decrease among women than among men, 
mainly	due	to	 lifestyle	changes,	as	 the	effect	of	 risk	 factor	 lowering	
treatment was small and similar between sexes.1 Improvements in sex 
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differences	in	discharge	medications	after	an	ACS	as	well	as	in	drug-	
eluting stents use might also have contributed to these results.6,7
Sex	and	gender	differences	concerning	ACS	are	described	in	sev-
eral	 categories,	 namely	 risk	 assessment,	 disease	 awareness,	 comor-
bidities, presentation, treatment and outcomes,8 contributing to a 
potential	 different	 access	 to	health	 care	between	women	and	men.	
Real-	world	 data	 about	 sex	 differences	 in	 management	 of	 ACS	 pa-
tients, treated in hospitals with diverse characteristics, and consider-
ing possible relative contraindications to an invasive approach and to 
revascularisation,	represent	an	operational	measurement	of	effective	
access.	We	aimed	to	analyse	sex	differences	in	management	of	ACS,	
controlling	for	age,	hospital	characteristics,	cardiovascular	risk	factors,	
previous medical history, complications at admission and coronary 
anatomy,	within	a	sample	of	Portuguese	hospitals	serving	both	urban	
and	rural	populations	and	with	different	levels	of	specialisation.
2  | METHODS
2.1 | Study design and sample selection
Data	 for	 this	 study	 were	 collected	 within	 the	 framework	 of	 the	
EURopean	Hospital	Benchmarking	by	Outcomes	in	acute	coronary	syn-
drome Processes (EURHOBOP) project, a collaborative, multicentre and 
multinational	retrospective	study	of	patients	consecutively	hospitalised	
with	a	discharge	diagnosis	of	ACS	from	70	hospitals	in	7	European	coun-
tries (Finland, France, Germany, Greece, Italy, Portugal, and Spain),9,10 
For	the	current	analysis	we	used	data	from	patients	admitted	to	the	10	
Portuguese	 hospitals,	which	were	 selected	 to	 cover	 different	 regions	
from	the	mainland	country,	from	north	to	south	and	west	to	east	and	
including both coastal and interior regions, urban and rural populations. 
Furthermore,	 these	 hospitals	 had	 different	 characteristics,	 regarding	
population	served,	 facilities,	 technical	and	human	resources,	and	spe-
cialisation levels. These diverse settings were selected with the purpose 
of	 seeking	 representativeness	 of	 the	 general	ACS	population.	Overall	
five	hospitals	had	a	catheterisation	laboratory,	three	had	a	cardiac	sur-
gery	department,	in	one	patients	with	ACS	were	admitted	to	the	internal	
medicine department, as the hospital had no cardiology department or 
cardiologists,	four	were	university	hospitals,	the	number	of	beds	ranged	
from	280	 to	1124	and	 the	populations	 served	 ranged	 from	 less	 than	
300 000 to more than 700 000 people. Each hospital contributed with 
approximately 300 consecutive patients discharged between 2008 and 
2010	with	diagnosis	of	ACS	(International	Classification	of	Diseases	10th	
revision:	 I.21.0-	I	 21.9	 and	 I.20.0).	 From	 3009	ACS	 patients	 included,	
those	with	missing	data	on	the	type	of	ACS	were	excluded	(n	=	68).
2.2 | Procedures and data collection
With	 the	use	of	 standardised	 forms,	 trained	 investigators	extracted	
data	from	discharge	letters,	emergency	room	records	and	laboratory	
systems.	When	necessary,	 different	 sources	were	 cross-	checked	 to	
ensure	completeness	and	quality	of	the	 information.	 Information	on	
type	of	ACS,	 demographic	 characteristics,	 previous	medical	 history,	
admission data, procedures used during hospitalisation, severity 
indicators and complications during hospitalisation, including vital 
status	and	in-	hospital	medication	(the	main	classes	of	recommended	
drugs	for	patients	with	ACS)11,12 was extracted.
2.3 | Definition of variables and data analysis
Patients	with	left	bundle	branch	block	were	defined	as	non-	classifiable	
(NC)	 ACS	 (NC	ACS)	 and	 analysed	with	 STEMI	 patients	 (STEMI/NC	
ACS	group).
The	management	was	 considered	 invasive	 if	 coronary	 angiogra-
phy	was	performed.	Reperfusion	was	defined	as	either	thrombolysis	
or primary percutaneous coronary intervention; revascularisation, ei-
ther as percutaneous coronary intervention (PCI) or coronary artery 
bypass	 graft	 (CABG).	 Anaemia	 was	 defined	 as	 haemoglobin	 below	
12	g/dL	for	females	and	below	13	g/dL	for	males13 and renal impair-
ment	was	 subdivided	 in	 two	 groups:	 estimated	 glomerular	 filtration	
rate (eGFR) below 30 mL/min/1.73 m2 and between 30 and 60 mL/
min/1.73 m2.14	Angiographic	coronary	disease	was	defined	as	normal/
mild	if	coronary	arteries	were	normal	or	with	stenosis	<30%;	moderate	
for	stenosis	between	30%	and	70%;	and	severe	 for	any	obstruction	
>70%	or	>50%	if	the	obstruction	was	in	the	left	main	coronary	artery.	
Severe	coronary	disease	was	further	divided	into	1-	,	2-	and	3-	vessels	
disease	categories,	according	to	the	number	of	affected	arteries.	 In-	
hospital	complications	were	evaluated	by	sex	and	type	of	ACS	through	
a	composite	endpoint	of	pulmonary	oedema,	shock,	acute	renal	fail-
ure,	re-	infarction,	stroke	and	a	drop	of	haemoglobin	of	3	or	more	g/dL.	
In-	hospital	death	was	also	assessed	separately	by	sex	and	type	of	ACS.
What is known
• Several studies have suggested that women with acute 
coronary	syndrome	are	more	likely	to	be	treated	with	a	
conservative strategy than men.
•	 Studies	 in	 different	 settings	 support	 that	 disparities	 in	
care	 and	 outcomes	 of	 women	 and	men	 persisted	 over	
time.
•	 Whether	this	sex-gap	in	management	is	observed	for	di-
agnostic	or	also	for	invasive	therapeutic	coronary	proce-
dures;	 and	 for	 the	whole	 spectrum	 of	 presentations	 of	
acute	coronary	syndrome,	managed	in	hospitals	with	dif-
ferent	levels	of	specialisation	is	controversial.
What is new
•	 Women	with	 ST-elevation	 acute	myocardial	 infarction/
non-classifiable	(left	bundle	branch	block)	acute	coronary	
syndrome, but not with non-ST-elevation acute coronary 
syndrome,	 were	 less	 frequently	 submitted	 to	 coronary	
angiography than men.
•	 No	differences	in	reperfusion	or	revascularisation	among	
those managed invasively were observed between 
women	and	men	for	the	whole	spectrum	of	acute	coro-
nary syndrome presentations.
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The	 proportions	 of	 prescription	 of	main	 classes	 of	 drugs	 during	
hospitalisation	were	 assessed	 for	 eligible	 patients,	 according	 to	 sex,	
type	of	ACS	and	management	approach,	namely	 invasive	vs	conser-
vative	(according	to	the	performance	or	not	of	coronary	angiography).	
We	computed	composite	variables	for	drugs	combinations:	double	an-
tiplatelet therapy with aspirin and clopidogrel, 3- drug treatment [(as-
pirin	or	clopidogrel)	and	beta-	blocker	and	statin]	and	5-	drug	treatment	
[aspirin	and	clopidogrel	and	beta-	blocker	and	(angiotensin-	converting	
enzyme	inhibitors	 (ACEi)	or	angiotensin	receptor	blockers	 (ARB)	and	
statin].	 For	 simple	 antiplatelet	 therapy	 (aspirin	 or	 clopidogrel),	 hae-
moglobin	below	10	g/dL	for	females	and	below	11	g/dL	for	males	at	
admission was considered a contraindication. For double antiplatelet 
therapy,	 besides	 a	 low	value	of	haemoglobin	 at	 admission,	 previous	
atrial	 fibrillation	 or	 being	 on	 oral	 anticoagulation	 at	 admission	were	
considered	 also	 contraindications.	 A	 systolic	 blood	 pressure	 lower	
than	 100	mm	 Hg	 or	 severe	 renal	 failure	 (eGFR	 less	 than	 30	ml/
min/1.73 m2)	at	admission	were	considered	contraindications	for	ACEi	
or	ARB.	Contraindications	for	beta-	blockers	were	systolic	blood	pres-
sure	lower	than	100	mm	Hg	or	heart	rate	below	50	bpm	at	admission.
Potential	 confounders	of	 the	association	between	sex	and	man-
agement	were	grouped	as	follows:	hospital	characteristics,	cardiovas-
cular	 risk	 factors,	 cardiovascular	 history,	 complications	 at	 admission	
and	angiographic	coronary	disease	(the	latter	for	the	revascularisation	
models	only).	In	the	univariate	analysis,	we	identified	which	variables	
were associated with management (P-	value<.15),	using	logistic	regres-
sion.	Within	each	group	mentioned	above,	variables	with	a	significant	
effect	 on	 the	 dependent	 variable	were	 included	 in	 the	multivariate	
model	and	a	backward	strategy	was	used	to	exclude	the	least	signifi-
cant	variables,	based	on	Wald	test	(P-	value	<.05).	To	fit	the	final	model,	
we	departed	from	all	variables	with	significant	effect	on	outcome	de-
rived	from	the	intragroup	multivariate	modelling,	repeated	backward	
strategy	to	choose	the	significant	variables	and	performed	likelihood	
ratio	 test	 for	boundary	p	value.	 In	 sensitivity	 analysis,	we	examined	
the	sex	differences	in	management	for	STEMI	group	excluding	the	NC	
ACS	patients.	Data	were	analysed,	using	stata	version	11	for	Windows	
(Stata	Corp	LP,	College	Station,	TX,	USA).
2.4 | Ethics
The	study	was	approved	by	 the	ethics	committee	of	 the	University	
of	 Porto	 Medical	 School	 and	 the	 National	 Commission	 for	 Data	
Protection. These two entities agreed that it would not be necessary 
to	ask	for	patients’	 informed	consent,	since	the	study	was	based	on	
the	collection	of	retrospective	clinical	data	from	the	medical	records	
during	hospitalisation,	and	 the	confidentiality	of	patients’	 identifica-
tion was assured.
3  | RESULTS
3.1 | Baseline characteristics
A	total	of	2941	patients	were	included,	1757	(59.7%)	with	NSTEACS	
diagnosis	and	1184	(40.3%)	with	STEMI/NC	ACS	(Tables	1	and	2).
The	proportions	of	women	included	by	hospital	varied	between	
27.5%	and	39.2%	and	the	mean	age	of	the	patients	between	64.1	
and	70.2	years	old	(Table	1).	In	the	majority	of	the	hospitals,	the	pro-
portion	of	patients	with	STEMI/NC	ACS	was	above	40%,	however,	
in three hospitals lower proportions were observed; the lowest was 
24.7%	in	a	hospital	without	catheterisation	 laboratory	and	cardiol-
ogy	ward	(Table	1).	Only	in	one	hospital,	the	proportion	of	patients	
with	 previous	 history	 of	 myocardial	 infarction,	 PCI	 or	 CABG	was	
below	20%.	The	proportions	of	patients	with	 complications	 at	 ad-
mission	varied	 between	38.7%	 and	61.1%	between	hospitals.	The	
two	hospitals	with	the	lowest	and	the	highest	proportions	of	com-
plications at admission were similar in characteristics, namely were 
tertiary hospitals, with catheterisation laboratory, located in the 
coast and covering an urban predominantly population. In all hos-
pitals,	most	patients	had	severe	angiographic	coronary	disease	of	at	
least	of	one	vessel.	The	proportion	of	patients	who	had	at	least	one	
in-	hospital	 complication	 varied	 between	 7.3%	 in	Hospital	 de	 Faro	
and	23.7%	in	Centro	Hospitalar	do	Porto.	The	in-	hospital	mortality	
varied	 between	 0.8%	 in	 Centro	Hospitalar	Alto	Ave	 and	 14.6%	 in	
Centro Hospitalar Cova da Beira, the latter is located in the interior, 
had	no	catheterisation	laboratory	and	cardiology	ward,	therefore	pa-
tients	with	ACS	were	admitted	to	the	internal	medicine	department	
(Table 1).
Compared	to	men,	women	with	either	ACS	type	were	older,	had	
more	frequently	hypertension	and	diabetes	and	were	less	frequently	
current	 smokers.	Women	 had	 more	 comorbidities	 than	 men,	 inde-
pendently	of	 the	ACS	type:	 they	suffered	more	often	from	previous	
heart	failure,	atrial	fibrillation	and	renal	failure.	In	the	NSTEACS	pop-
ulation,	previous	myocardial	infarction,	PCI	or	CABG	were	more	prev-
alent	in	men.	Anaemia	and	renal	impairment	at	admission	were	more	
prevalent	 in	 women,	 who	 presented	 less	 often	 with	 severe	 angio-
graphic coronary disease (Table 2). Compared with men, the compos-
ite	endpoint	of	 in-	hospital	complications	(pulmonary	oedema,	shock,	
acute	renal	failure,	reinfarction,	stroke,	drop	in	haemoglobin	of	3	g/dL	
or	more)	was	more	frequently	observed	among	women	with	NSTEACS	
(15.3%	vs	11.2%,	P	=	.014)	and	with	STEMI/NC	ACS	(19.7%	vs	13.8%,	
P	=	.011).	Of	all	patients	included	in	this	analysis,	5.1%	of	women	and	
3.7%	 of	 men	 with	 NSTEACS	 died	 during	 hospitalisation	 (P	=	.159),	
while	among	STEMI/NC	ACS	patients,	 in-	hospital	death	was	signifi-
cantly	 higher	 among	women	 than	men	 (17.9%	vs	 8.3%,	P<.001,	 re-
spectively) (Table 2).
3.2 | Management
Compared with patients treated conservatively, women and men 
with	NSTEACS	or	STEMI/NC	ACS	who	were	treated	invasively	more	
frequently	had	prescription	of	 the	several	 recommended	classes	of	
drugs	 during	 hospitalisation.	 Patients	 with	 STEMI/NC	 ACS,	 both	
women and men, managed conservatively were the subgroup who 
had	 the	 lowest	 prescription	 of	 recommended	 drugs	 during	 hospi-
talisation	(Figure	1).	Women	with	NSTEACS	managed	conservatively	
were	 significantly	 less	 likely	 to	 receive	 statins	 (54.2%	 vs	 64.7%,	
P	=	.009)	 and	 5-	drug	 treatment	 (20.7%	 vs	 34.3%,	 P = .002) than 
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men	 with	 NSTEACS	 managed	 conservatively;	 while	 women	 with	
NSTEACS	managed	invasively	were	more	likely	to	receive	an	ACEi/
ARB	 during	 hospitalisation	 than	men	with	 the	 same	 diagnosis	 and	
management	approach	(69.3%	vs	61.9%,	P = .037, respectively). The 
remaining	sex	differences	in	prescription	of	drugs	during	hospitalisa-
tion	among	patients	without	 contraindications	were	not	 significant	
(Figure 1).
An	 invasive	 strategy	 was	 less	 frequent	 in	 women,	 regardless	
of	the	type	of	ACS	(56.6%	vs	71.8%,	P<.001,	and	62.5%	vs	80.8%,	
P<.001	 among	 patients	 with	 NSTEACS	 and	 STEMI/NC	 ACS,	 re-
spectively).	The	difference	in	the	odds	of	being	managed	invasively	
between	sexes	was	observed	in	the	STEMI/NC	ACS	group,	after	ad-
justment	for	patient	and	hospital	characteristics	(adjusted	odds	ratio	
[OR]	 1.64,	 95%	 confidence	 interval	 [95%	 CI]	 1.11-	2.44).	 Among	
patients	 performing	 coronary	 angiography,	 52.7%	 and	 76.5%	 of	
women	and	58.3%	and	81.6%	of	men	with	NSTEACS	and	STEMI/
NC	ACS,	 respectively,	were	 submitted	 to	 revascularisation.	 There	
was	 no	 difference	 by	 sex	 in	 the	 odds	 of	 revascularisation	 in	 both	
TABLE  2 Baseline	characteristics	of	patients	with	different	types	of	acute	coronary	syndrome,	by	sex
NSTEACS STEMI/NC ACS
Women Men P Women Men P
634 (36.1) 1123 (63.9) 341 (28.8) 843 (71.2)
Age	(y),	mean	(SD) 73.2 (11.8) 65.7	(12.7) <.001 73.2 (13.6) 63.1	(13.5) <.001
Cardiovascular	risk	factors
Hypertension 500	(78.9) 751	(66.9) <.001 246 (72.1) 461	(54.7) <.001
Diabetes 275	(43.4) 351	(31.3) <.001 104	(30.5) 206 (24.4) .032
Dyslipidaemia 327	(51.6) 634	(56.5) .049 146 (42.8) 384	(45.6) .391
Current	smoking 34	(5.4) 306 (27.3) <.001 29	(8.5) 323 (38.3) <.001
Cardiovascular history
Previous	MI,	PCI	or	CABG 156	(24.6) 382 (34.0) <.001 46	(13.5) 122	(14.5) .661
Previous HF 87 (13.7) 101 (9.0) .002 45	(13.2) 34 (4.0) <.001
Previous	AF 55	(8.7) 72 (6.4) .078 29	(8.5) 35	(4.2) .003
Chronic	renal	failure 214 (33.8) 236 (21.0) <.001 97	(28.5) 136 (16.1) <.001
Previous	stroke 67 (10.6) 98 (8.7) .204 31 (9.1) 52	(6.2) .074
Peripheral artery disease 21 (3.3) 59	(5.3) .061 4 (1.2) 20 (2.4) .185
Complications at admission
Pulmonary	oedema	or	shock 9 (1.4) 8 (0.7) .146 10 (2.9) 23 (2.7) .847
Anaemia 238 (39.0) 300 (28.0) <.001 115	(35.6) 156	(19.3) <.001
Renal impairment (GFR)
30	to	<60	ml/min/1.73	m2 264 (43.1) 257	(23.9) 136 (42.4) 182 (22.7)
<30	ml/min/1.73	m2 79 (12.9) 91	(8.5) <.001 44 (13.7) 38 (4.7) <0.001
Angiographic	coronary	disease
Normal/Mild 67 (18.8) 59	(7.5) 15	(7.1) 19 (2.8)
Moderate 15	(4.2) 34 (4.3) 5	(2.4) 11 (1.6)
Severe—1 vessel 117 (32.9) 254	(32.2) 105	(50.0) 347	(51.3)
Severe—2 vessels 78 (21.9) 227 (28.8) 48 (22.9) 180 (26.6)
Severe—3 vessels 79 (22.2) 215	(27.3) <.001 37 (17.6) 119 (17.6) .054
In- hospital complications
Pulmonary	oedema,	shock,	acute	
renal	failure,	re-	infarction,	stroke,	
drop	in	haemoglobin	≥3	g/dL
97	(15.3) 126 (11.2) .014 67 (19.7) 116 (13.8) .011
In- hospital death 32	(5.1) 41 (3.7) .159 61 (17.9) 70 (8.3) <.001
Total may not add to 2941 due to missing data.
Data are counts with percentages unless otherwise indicated.
AF,	atrial	fibrillation;	CABG,	coronary	artery	bypass	surgery;	GFR,	glomerular	filtration	rate;	HF,	heart	failure;	MI,	myocardial	infarction;	NSTEACS,	non-	ST-	
elevation	acute	coronary	syndrome;	PCI,	percutaneous	coronary	intervention;	SD,	standard	deviation;	STEMI/NC	ACS,	ST-	elevation	myocardial	infarction/
Non-	classifiable	acute	coronary	syndrome.
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NSTEACS	 (0.84,	 0.61-	1.14)	 and	 STEMI/NC	ACS	 (1.00,	 0.62-	1.62)	
after	 adjustment	 (Table	3).	 More	 men	 than	 women	 with	 STEMI/
NC	ACS	 had	 reperfusion	 therapy	 (67.9%	 vs	 49.3%,	 respectively).	
However,	 this	 significant	crude	association	between	male	sex	and	
reperfusion	(2.17,	1.68-	2.84)	was	explained	after	multivariable	ad-
justment	 (1.33,	0.96-	1.84).	 In	 the	sensitivity	analysis,	NC	ACS	pa-
tients (n = 163) were excluded and the results were comparable to 
primary results (Table 4).
4  | DISCUSSION
This	 study	 shows	 that	 women	 with	 STEMI/NC	 ACS,	 but	 not	 with	
NSTEACS,	were	 less	 frequently	 submitted	 to	 coronary	 angiography	
than	men,	 after	 controlling	 for	 age,	 characteristics	 of	 the	 hospitals,	
cardiovascular	risk	factors,	previous	medical	history	and	complications	
at	admission.	No	significant	differences	between	sexes	in	the	perfor-
mance	of	reperfusion	and	revascularisation	were	observed.
F IGURE  1 Proportion	of	patients	treated	with	pharmacological	treatment	during	hospitalisation	for	acute	coronary	syndrome	with	or	
without ST- elevation according to sex and management approach.
*P-value <.05
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We	 included	 10	 hospitals	with	 different	 levels	 of	 specialisation,	
located	in	heterogeneous	geographic	areas.	The	analysis	of	the	char-
acteristics	of	the	patients	included	by	hospital	identified	differences	in	
ACS	epidemiology	and	outcomes.	Between	and	within	country	differ-
ences	in	management	and	outcomes	of	patients	with	ACS	have	been	
described, but remain poorly understood.10,15,16 In Portugal, between 
1981	 and	 2012,	 relative	 declines	 of	 CHD	mortality	 indicators	were	
different	by	geographic	region;	consistent	decreases	in	mortality	rates	
were only observed in the most populated and urbanised regions.5 
Our	finding	of	significant	differences	by	hospital	in	in-	hospital	mortal-
ity	of	patients	with	ACS	deserves	further	analysis.
Of	patients	hospitalised	with	NSTEACS	and	with	STEMI/NC	ACS	
36.1%	and	28.8%,	respectively,	were	women,	similar	proportions	to	
the observed in the whole EURHOBOP sample.10	 Approximately	
40%	of	patients	of	our	sample	were	diagnosed	with	STEMI/NC	ACS;	
data	 from	 the	 Portuguese	 Registry	 of	 Acute	 Coronary	 Syndrome	
(ProACS)	 reported	 a	 similar	 proportion	 (41.2%).17 The prevalence 
of	cardiovascular	risk	factors	 in	women	and	men	with	ACS,	higher	
among	patients	with	NSTEACS	is	also	in	line	with	other	national	and	
international data.10,17	Particularly	relevant	is	the	high	prevalence	of	
diabetes	in	our	sample,	particularly	among	women	with	NSTEACS,	
higher than the observed in other countries.10	For	both	types	of	ACS	
data	from	the	overall	EURHOBOP	study	showed	that	Portugal	had	
one	of	the	highest	proportions	of	in-	hospital	events	and	mortality,	
even	 after	 exhaustive	 model	 adjustment.10	 Analysing	 data	 sepa-
rately	by	sex	and	type	of	ACS,	we	were	able	to	identify	a	subgroup	of	
patients	with	particularly	high	risk	of	in-	hospital	death,	women	with	
STEMI/NC	ACS	 (17.9%).	 Considering	 prescription	 of	 drugs	 during	
hospitalisation,	higher	differences	were	observed	between	patients	
with	different	management	approaches,	than	between	women	and	
men. The decision to proceed or not to an invasive approach may 
influence	the	prescription	of	recommended	drugs	for	patients	with	
ACS,	not	only	antiplatelet	therapy,	which	is	expected,	but	probably	
other	classes	of	drugs.	Our	results	are	in	line	with	previous	findings	
TABLE  3 Sex	differences	in	in-	hospital	management,	by	type	of	acute	coronary	syndrome	(women	are	the	reference	class)
Women  
n (%)
Men  
n (%) Crude OR (95% CI)
Adjusted OR 
(95% CI) Adjustment variables
NSTEACS
Diagnostic 
catheterisation
359	
(56.6)
806 
(71.8)
1.94	(1.59-	2.39) 1.26 (0.99- 1.62) Patient characteristics: age, dyslipidaemia, 
history	of	heart	failure,	stroke,	renal	impair-
ment at admission, anaemia at admission
Hospital	characteristics:	number	of	beds
Revascularisationa 189 
(52.7)
470 
(58.3)
1.26 (0.98- 1.62) 0.84 (0.61- 1.14) Patient characteristics: age, renal impairment at 
admission, angiographic coronary disease
Hospital	characteristics:	presence	of	catheterisa-
tion laboratory, university hospital
STEMI/NC	ACS
Diagnostic 
catheterisation
214 
(62.5)
681 
(80.8)
2.53	(1.91-	3.34) 1.64 (1.11- 2.44) Patient characteristics: age, dyslipidaemia, 
smoking,	history	of	myocardial	infarction,	
percutaneous intervention or coronary artery 
bypass	surgery,	of	heart	failure,	of	stroke,	of	
renal	failure,	renal	impairment	at	admission
Hospital	characteristics:	presence	of	catheterisa-
tion	laboratory,	number	of	beds
Reperfusionb 168 
(49.3)
572	
(67.9)
2.17 (1.68- 2.81) 1.33 (0.96- 1.84) Patient characteristics: age, dyslipidaemia, 
smoking,	history	of	myocardial	infarction,	
percutaneous intervention or coronary artery 
bypass	surgery,	of	heart	failure,	renal	
impairment and anaemia at admission
Hospital	characteristics:	presence	of	catheterisa-
tion laboratory, cardiothoracic surgery 
department
Revascularisationa 163 
(76.5)
555	
(81.6)
1.35	(0.93-	1.96) 1.00 (0.62- 1.62) Patient	characteristics:	age,	history	of	renal	
failure,	anaemia	at	admission,	angiographic	
coronary disease
Hospital	characteristics:	presence	of	catheterisa-
tion laboratory
CI,	confidence	interval;	NSTEACS,	non-	ST-	elevation	acute	coronary	syndrome;	OR,	odds	ratio;	STEMI/NC	ACS,	ST-elevation	myocardial	infarction/Non-	
classifiable	acute	coronary	syndrome.
aPercutaneous coronary intervention and/or coronary artery bypass surgery among those submitted to coronary angiography.
bThrombolysis or primary percutaneous coronary intervention.
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of	very	few	sex	differences	in	discharge	medications	of	patients	with	
ACS	in	Portugal,	after	adjusting	for	the	potential	confounding	effect	
of	age,	comorbidities	and	contraindications.6	Women	and	men	differ	
in	the	pathophysiology	and	mechanisms	of	coronary	heart	disease.	
Women	with	ACS	are	on	average	older	than	men,	suffer	from	more	
comorbidities, are more prone to atypical presentations, thrombus 
formation	and	plaque	erosion,	but	less	prone	to	suffer	from	severe	
obstructive coronary artery disease.18,19	Women	encounter	 longer	
delays	between	 the	onset	of	 symptoms	and	 first	medical	 contact,	
arrival at a hospital and evidence- based treatment.8	Additionally	al-
though	lower	cardiac	catheterisation	rates	seen	in	women	with	ACS	
were	considered	to	be	partially	due	to	women’s	own	preferences,20 
recent	data	suggest	that	differences	in	catheterisation	rates	by	sex	
may	be	driven	 largely	by	physicians,	 through	different	patterns	of	
counselling	and	 referral	 to	cardiovascular	 testing	between	women	
and	men,	and	not	by	differential	attitudes,	behaviours	and	decisions	
of	female	patients.21
Considering access to healthcare in a multilevel perspective, both 
factors	related	to	health	care	systems	and	to	patient22	explain	the	dif-
ference	in	management	of	women	and	men	with	ACS.	Several	deter-
minants,	at	both	levels,	that	are	not	independent	and	influence	each	
other	and	operate	at	different	times	during	the	process	of	illness	and	
care,	 probably	 enable	 or	 hinder	 differently	 in	women	 and	men,	 the	
ability	to	perceive,	seek,	reach,	pay	and	engage	in	health	care	and	the	
ability	of	the	system	to	fulfil	the	needs	of	the	patient.22
Compared	with	data	reported	by	the	ProACS	from	2010	to	2013,	
a	 lower	proportion	of	NSTEACS	patients	 in	 the	EURHOBOP	cohort	
were	treated	invasively	(66.3%	vs	84.8%).3	Although	part	of	this	dif-
ference	may	be	dependent	on	a	true	increase	in	the	invasive	treatment	
of	patients	with	ACS,	the	results	observed	in	the	ProACS	may	be	an	
overestimation	of	the	true	proportion,	due	to	the	fact	that	only	hos-
pitals with higher specialisation levels were included in this registry. 
In	NSTEACS	patients,	only	 those	with	unstable	 angina,	without	 risk	
criteria and no recurrent symptoms are recommended a non- invasive 
testing	for	ischaemia	(preferably	with	imaging)	before	deciding	on	an	
invasive evaluation.11	All	the	others	should	be	treated	invasively,	un-
less	some	contraindication	exists	or	the	risks	appear	to	outweigh	the	
benefits.	The	factors	that	should	be	taken	into	account	to	weigh	risks	
and	benefits	are	related	with	clinical	presentation,	comorbidities,	risk	
stratification,	frailty,	cognitive	status	and	estimated	life	expectancy.11 
After	 adjusting	 for	 several	 of	 these	 factors,	 no	difference	 in	perfor-
mance	of	coronary	angiography	between	sexes	was	observed	 in	the	
NSTEACS	group,	representing	an	improvement	in	the	sex	equality	of	
access to evidence- based treatment.2
In	 STEMI	 patients,	 the	main	 limitation	 to	 reperfusion	 therapy	 is	
the	 time	of	presentation	after	 symptoms	onset.	Early	mechanical	or	
pharmacological	reperfusion	should	be	performed	within	the	first	12	
hours	from	symptoms	onset;	whether	PCI	is	also	beneficial	in	patients	
presenting	more	 than	12	hours	 after	 symptoms	onset	 is	more	 con-
troversial.12	The	use	of	reperfusion	therapy	in	our	sample	is	similar	to	
the	observed	in	ProACS	covering	years	2002-	2008	(62.5%	vs	61.9%,	
respectively),23	but	 lower	than	the	observed	 in	 the	second	phase	of	
the	 ProACS	 (84.8%).17	 Implementation	 of	 a	 pre-	hospital	 fast-	track	
network	 in	 Portugal	 improved	 reperfusion	 rates	 in	 STEMI	 patients,	
through an increase in primary angioplasty.4	Studies	performed	with	
data	from	the	ProACS	were	not	reported	by	sex,	which	limits	further	
comparisons.	Among	STEMI/NC	ACS	patients,	different	probabilities	
of	performing	coronary	angiography	by	sex	might	result	from	distinct	
patient and hospital delays.8 In 2008, Portugal was among the coun-
tries	performing	less	primary	PCI	in	Europe.24	One	major	factor	con-
tributing	for	this	finding	might	be	the	high	proportion	(55%)	of	patients	
who	were	admitted	more	than	12	hours	after	symptom	onset;4 with 
higher delays being expected among women. The subjective experi-
ence	of	symptoms	 influences	patients’	attitudes	 in	help	seeking	and	
professionals’	 interpretation	 of	 clinical	 presentations,	 thus	 affecting	
access	to	effective	health	care.25
TABLE  4 Sex	differences	in	in-	hospital	management	of	patients	with	ST-	elevation	myocardial	infarction	(women	are	the	reference	class)
Women  
n (%)
Men  
n (%) Crude OR (95% CI)
Adjusted OR (95% 
CI) Adjustment variables
STEMI
Diagnostic 
catheterisation
189 
(72.1)
636 
(83.8)
2.00 (1.43- 2.78) 1.99 (1.31- 3.00) Patient characteristics: age, dyslipidaemia, 
history	of	stroke,	of	renal	failure
Hospital	characteristics:	presence	of	catheteri-
sation	laboratory,	number	of	beds
Reperfusiona 162 
(61.8)
559	
(73.7)
1.72 (1.28- 2.32) 1.37 (0.97- 1.94) Patient characteristics: age, dyslipidaemia, renal 
impairment at admission
Hospital	characteristics:	presence	of	catheteri-
sation laboratory
Revascularisationb 152	
(80.4)
529	
(83.2)
1.20 (0.79- 1.82 1.01 (0.60- 1.70) Patient characteristics: age, angiographic 
coronary disease
Hospital	characteristics:	presence	of	catheteri-
sation laboratory
CI,	confidence	interval;	OR,	odds	ratio;	STEMI,	ST-	elevation	myocardial	infarction.
aThrombolysis or primary percutaneous coronary intervention.
bPercutaneous coronary intervention and/or coronary artery bypass surgery among those submitted to coronary angiography.
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In	both	 types	of	ACS,	no	differences	 in	 revascularisation	among	
those managed invasively were observed between women and men. 
This	also	represents	a	sex-	gap	improvement	in	access	to	care.	When	
the	 decision	 to	 proceed	 to	 an	 invasive	 approach	 is	made,	 risks	 and	
benefits	 of	 revascularisation	 have	 already	 been	 evaluated.26 In our 
cohort,	 a	 significant	proportion	of	patients	of	both	 sexes,	especially	
in	 the	NSTEACS	 group	was	 not	 revascularised.	 Clinical	 and/or	 ana-
tomic reasons such as non- obstructive coronary heart disease, or 
coronary lesions not amenable to intervention, as well as patient and 
system	delays	for	STEMI/NC	ACS,	may	explain	these	revascularisation	
proportions.
4.1 | Limitations
Given	 the	 retrospective	 nature	 of	 this	 study	 and	 the	 data	 sources,	
the	validity	of	the	conclusions	relies	on	the	accuracy	and	complete-
ness	of	the	original	documentation.	Although	we	considered	the	main	
confounding	variables	at	the	individual	and	hospital	level,	no	detailed	
information	on	 socioeconomic	 status,	 clinical	presentation	and	 time	
delays was available.
5  | CONCLUSIONS
In	 a	 real-	life	 setting,	women	with	STEMI/NC	ACS	are	 less	 likely	
than	men	 to	 be	managed	 invasively.	 No	 sex	 differences	 in	 rep-
erfusion	 and	 revascularisation	 were	 observed	 in	 both	 types	 of	
ACS,	which	represents	an	important	achievement,	and	help	to	un-
derstand the greater declines in CHD mortality observed among 
women compared to men in Portugal. Further improvements are 
still	 necessary,	 especially	 in	 the	 management	 of	 women	 with	
STEMI/NC	ACS.	To	reduce	inequalities	in	management	of	patients	
with	ACS	in	Portugal,	the	sex-	gap	in	analysis	and	report	of	results	
from	national	registries	and	other	data	sources	must	be	improved,	
and patients admitted to hospitals with lower specialisation levels 
should be included.
ACKNOWLEDGEMENTS
The	authors	gratefully	acknowledge	the	collaboration	of	the	hospi-
tals and local researchers who participated in the Eurhobop study: 
Centro	 Hospitalar	 de	 Vila	 Nova	 de	 Gaia/Espinho	 (Vasco	 Gama	
Ribeiro, Gustavo Pires de Morais), Centro Hospitalar do Porto 
(Severo Torres, Mário Santos), Centro Hospitalar Cova da Beira 
(Miguel Castelo Branco), Centro Hospitalar de São João (Sílvia 
Marta Oliveira), Hospital de Faro (Ilídio de Jesus, Jorge Mimoso), 
Hospital Pedro Hispano (Filomena Monteiro), Unidade Hospitalar 
de	Bragança	(Domingos	Fernandes),	Centro	Hospitalar	do	Alto	Ave	
(João	Almeida,	 Filipa	 Canário	Almeida,	 Francisco	Castro	 Ferreira),	
Centro	 Hospitalar	 de	 Lisboa	 Norte	 (António	 Nunes	 Diogo,	Maria	
José	Correia),	Hospital	de	Santo	André	–	Leiria	(João	Morais,	Sidarth	
Pernencar).
DISCLOSURES
The authors stated that they had no interests which might be per-
ceived	as	posing	a	conflict	or	bias.
FUNDING
This	 work	 was	 supported	 by	 Executive	 Agency	 for	 Health	 and	
Consumers (2008 13 12 - EURHOBOP) and Unidade de Investigação 
em Epidemiologia - Instituto de Saúde Pública da Universidade do Porto 
(EPIUnit)	(POCI-	01-	0145-	FEDER-	006862;	Ref.UID/DTP/04750/2013).
AUTHOR CONTRIBUTIONS
Carla	Araújo	participated	 in	data	collection,	collaborated	 in	the	field	
work,	 raised	the	hypotheses,	analysed	and	 interpreted	the	data	and	
drafted	the	first	version	of	the	manuscript.	Marta	Pereira	participated	
in	data	collection,	collaborated	in	the	field	work,	analysed	and	inter-
preted	the	data	and	revised	the	final	version	of	the	manuscript.	Olga	
Laszczyńska	analysed	and	interpreted	the	data,	and	revised	the	final	
version	of	the	manuscript.	Paula	Dias	interpreted	the	data	and	revised	
the	 final	 version	 of	 the	 manuscript.	 Ana	 Azevedo	 coordinated	 the	
Portuguese collaboration in EURHOBOP study, raised the hypoth-
eses,	interpreted	the	data	and	revised	the	final	version	of	the	manu-
script.	Each	author	participated	sufficiently	in	the	work	to	take	public	
responsibility	for	its	content	and	all	authors	approved	the	final	version	
of	the	manuscript.
ORCID
Carla Araújo  http://orcid.org/0000-0003-4279-9570 
REFERENCES
	 1.	 Pereira	M,	Azevedo	A,	Lunet	N,	et	al.	Explaining	the	decline	in	coro-
nary	heart	disease	mortality	in	Portugal	between	1995	and	2008.	Circ 
Cardiovasc Qual Outcomes. 2013;6:634-642.
	 2.	 Hansen	KW,	Soerensen	R,	Madsen	M,	et	al.	Developments	in	the	in-
vasive	diagnostic-	therapeutic	cascade	of	women	and	men	with	acute	
coronary	syndromes	from	2005	to	2011:	A	nationwide	cohort	study.	
BMJ Open.	2015;5:e007785.
	 3.	 Moreira	D,	Marmelo	B,	Delgado	A,	et	al.	A	conservative	strategy	in	non-	
ST-	segment	elevation	myocardial	infarction	-	constraints	and	progno-
sis: The situation in Portugal. Rev Port Cardiol.	2015;34:315-328.
 4. Pereira H, Campante Teles R, Costa M, et al. Trends in primary angio-
plasty	 in	Portugal	 from	2002	 to	2013	according	 to	 the	Portuguese	
National	 Registry	 of	 Interventional	 Cardiology.	 Rev Port Cardiol. 
2016;35:395-404.
	 5.	 Araujo	C,	 Pereira	M,	Viana	M,	 et	 al.	 Regional	variation	 in	 coronary	
heart disease mortality trends in Portugal, 1981- 2012. Int J Cardiol. 
2016;224:279-285.
	 6.	 Pereira	M,	Araujo	C,	Dias	P,	et	al.	Age	and	sex	inequalities	in	the	pre-
scription	 of	 evidence-	based	 pharmacological	 therapy	 following	 an	
acute coronary syndrome in Portugal: The EURHOBOP study. Eur J 
Prev Cardiol. 2014;21:1401-1408.
	 7.	 Barros	 V,	 Pereira	 M,	 Araujo	 C,	 Braga	 P,	 Azevedo	 A.	 Use	 of	 drug-	
eluting	versus	bare-	metal	stents	after	an	acute	coronary	syndrome	in	
Portugal: The EURHOBOP study. Rev Port Cardiol.	2015;34:449-456.
10 of 10  |     ARAÚJO et Al.
	 8.	 Graham	 G.	 Acute	 coronary	 syndromes	 in	 women:	 Recent	 treat-
ment trends and outcomes. Clinical Medicine Insights Cardiology. 
2016;10:1-10.
	 9.	 Degano	IR,	Subirana	I,	Torre	M,	et	al.	A	European	benchmarking	sys-
tem to evaluate in- hospital mortality rates in acute coronary syn-
drome: The EURHOBOP project. Int J Cardiol.	2015;182:509-516.
	10.	 Andre	R,	Bongard	V,	Elosua	R,	et	al.	International	differences	in	acute	
coronary	 syndrome	 patients’	 baseline	 characteristics,	 clinical	 man-
agement	and	outcomes	in	Western	Europe:	The	EURHOBOP	study.	
Heart. 2014;100:1201-1207.
	11.	 Roffi	M,	Patrono	C,	Collet	JP,	et	al.	2015	ESC	Guidelines	for	the	man-
agement	of	acute	coronary	syndromes	in	patients	presenting	without	
persistent	ST-	segment	elevation:	Task	Force	for	the	Management	of	
Acute	Coronary	Syndromes	in	Patients	Presenting	without	Persistent	
ST-	Segment	Elevation	of	 the	European	Society	of	Cardiology	 (ESC).	
Eur Heart J.	2016;37:267-315.
	12.	 Ibanez	 B,	 James	 S,	 Agewall	 S,	 et	 al.	 ESC	 Guidelines	 for	 the	 man-
agement	 of	 acute	myocardial	 infarction	 in	 patients	 presenting	with	
ST-	segment	elevation:	The	Task	Force	for	the	management	of	acute	
myocardial	 infarction	 in	patients	presenting	with	ST-	segment	eleva-
tion	of	the	European	Society	of	Cardiology	(ESC).	Eur Heart J. 2017. 
doi:	101093/eurheartj/ehx393	[Epub	ahead	of	print].
	13.	 Nutritional	anaemias.	Report	of	a	WHO	scientific	group.	World Health 
Organ Tech Rep Ser.	1968;405:5-37.
	14.	 Levey	AS,	Coresh	J,	Greene	T,	et	 al.	Expressing	 the	modification	of	
diet	 in	 renal	 disease	 study	 equation	 for	 estimating	 glomerular	 fil-
tration rate with standardized serum creatinine values. Clin Chem. 
2007;53:766-772.
	15.	 Kolte	D,	 Khera	 S,	Aronow	WS,	 et	 al.	 Regional	 variation	 across	 the	
United	 States	 in	 management	 and	 outcomes	 of	 ST-	elevation	myo-
cardial	infarction:	Analysis	of	the	2003	to	2010	nationwide	inpatient	
sample database. Clin Cardiol. 2014;37:204-212.
	16.	 Menon	V,	Rumsfeld	JS,	Roe	MT,	et	al.	Regional	outcomes	after	ad-
mission	for	high-	risk	non-	ST-	segment	elevation	acute	coronary	syn-
dromes. Am J Med.	2006;119:584-590.
 17. Magalhaes P, Mateus P, Carvalho S, et al. Relationship between treat-
ment	delay	and	type	of	reperfusion	therapy	and	mechanical	complica-
tions	of	acute	myocardial	infarction.	Eur Heart J Acute Cardiovasc Care. 
2016;5:468-474.
	18.	 Pepine	CJ,	Ferdinand	KC,	Shaw	LJ,	et	al.	Emergence	of	nonobstructive	
coronary	artery	disease:	A	woman’s	problem	and	need	for	change	in	
definition	on	angiography.	J Am Coll Cardiol.	2015;66:1918-1933.
	19.	 Reynolds	HR,	Srichai	MB,	Iqbal	SN,	et	al.	Mechanisms	of	myocardial	
infarction	 in	women	without	 angiographically	 obstructive	 coronary	
artery disease. Circulation.	2011;124:1414-1425.
	20.	 Heidenreich	 PA,	 Shlipak	 MG,	 Geppert	 J,	 McClellan	 M.	 Racial	 and	
sex	 differences	 in	 refusal	 of	 coronary	 angiography.	 Am J Med. 
2002;113:200-207.
	21.	 Golden	KE,	Chang	AM,	Hollander	JE.	Sex	preferences	in	cardiovascu-
lar	testing:	The	contribution	of	the	patient-	physician	discussion.	Acad 
Emerg Med. 2013;20:680-688.
	22.	 Levesque	JF,	Harris	MF,	Russell	G.	Patient-	centred	access	 to	health	
care:	Conceptualising	access	at	 the	 interface	of	health	systems	and	
populations. Int J Equity Health. 2013;12:18.
	23.	 Santos	 JF,	 Aguiar	 C,	 Gavina	 C,	 Azevedo	 P,	 Morais	 J.	 Portuguese	
Registry	of	Acute	Coronary	Syndromes:	Seven	years	of	activity.	Rev 
Port Cardiol.	2009;28:1465-1500.
	24.	 Widimsky	P,	Wijns	W,	Fajadet	J,	et	al.	Reperfusion	therapy	for	ST	ele-
vation	acute	myocardial	infarction	in	Europe:	Description	of	the	cur-
rent situation in 30 countries. Eur Heart J.	2010;31:943-957.
	25.	 Canto	JG,	Rogers	WJ,	Goldberg	RJ,	et	al.	Association	of	age	and	sex	
with	 myocardial	 infarction	 symptom	 presentation	 and	 in-	hospital	
mortality. JAMA. 2012;307:813-822.
	26.	 Windecker	S,	Kolh	P,	Alfonso	F,	et	al.	2014	ESC/EACTS	Guidelines	on	myo-
cardial	revascularization:	The	Task	Force	on	Myocardial	Revascularization	
of	the	European	Society	of	Cardiology	(ESC)	and	the	European	Association	
for	 Cardio-	Thoracic	 Surgery	 (EACTS)Developed	 with	 the	 special	 con-
tribution	 of	 the	 European	Association	 of	 Percutaneous	 Cardiovascular	
Interventions	(EAPCI).	Eur Heart J.	2014;35:2541-2619.
How to cite this article:	Araújo	C,	Pereira	M,	Laszczyńska	O,	
Dias	P,	Azevedo	A.	Sex-	related	inequalities	in	management	of	
patients	with	acute	coronary	syndrome—results	from	the	
EURHOBOP study. Int J Clin Pract. 2018;72:e13049. https://doi.
org/10.1111/ijcp.13049
